
|Articles|April 10, 2008
Novartis to acquire eye care company Alcon Inc.
Novartis is set to pay as much as $39 biliion to buy a controlling stake in Alcon, a Houston company that dominates the eye care market.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Finerenone Shows Benefits for Chronic Kidney Disease for Patients With Type 1 Diabetes
2
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Q&A: Fentanyl, Opiophobia Concurrently Contribute to Ongoing Opioid Crisis
5




















































































































































